Teon Therapeutics, a biopharmaceutical company, has closed $30 million in Series A financing. Oceanpine Capital led the round with participation other investors that include Oriza Ventures, Lifespan Investments, Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: